openPR Logo
Press release

A Stupendous CAGR Of 13% Between 2020 to 2030 To Be Clocked By The Atrial Fibrillation Devices Market

A Stupendous CAGR Of 13% Between 2020 to 2030 To Be Clocked By

The Atrial Fibrillation Devices Market will witness a CAGR of 13%, reaching Expand Almost 4X between 2020 to 2030. With medical IoT implying the use of wearable monitors, devices, and various integrated applications regarding healthcare needs, the healthcare vertical is bound to scale new-fangled heights in the upcoming period. This is what the healthcare vertical would all be in the next 10 years.

Interventional electrophysiology devices have already had a significant impact on patients suffering from cardiac arrhythmias, and are being increasingly adopted as a permanent treatment option for atrial fibrillation. Procedures such as radiofrequency ablation, cryoablation, and cox-maze are well performed in today’s practice.

Planning Forward? Access Sample Of Atrial Fibrillation Devices Market Report! https://www.persistencemarketresearch.co/samples/31531

Recent studies have found cryoablation to be more effective than medical management, and it is widely used in medical surgical practice. The overall market is primarily driven by the growing prevalence of atrial fibrillation amongst the geriatric as well as adult population, and the adoption of minimally-invasive techniques for the permanent treatment of atrial fibrillation.

Moreover, the use of innovative techniques, advancements in technology, and favorable reimbursement scenario are some other factors responsible for propelling the growth of the atrial fibrillation devices market.

Companies covered in Atrial Fibrillation Devices Market Report

Biosensense Webster, Inc. (Johnson & Johnson)
Abbott Laboratories
Medtronic Plc
Boston Scientific Corporation
AtriCure, Inc.
Japan Lifeline Co.
MicroPort Scientific Corporation
Biomerics
CathRx

How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Atrial Fibrillation Devices Market? https://www.persistencemarketresearch.co/methodology/31531

As such, the global atrial fibrillation devices market is estimated to be valued at US$ 3.9 Bn in 2020, with the market expected to exhibit a healthy CAGR of more than 14% during the forecast period (2020-2030).

Key Takeaways from Atrial Fibrillation Devices Market Study

The diagnostics segment, by product, is expected to gain maximum revenue share over the forecast period. The therapeutic segment is anticipated to increase at a CAGR of 15% over 2020–2030, to reach US$ 8.3 Bn by 2030.

According to PMR data collected from electrophysiologists in various regions, radiofrequency catheter ablation is the procedure of choice due to the high success rate, while cryoablation is the second preference for atrial fibrillation catheter ablation.

By technology, the radiofrequency and cryoablation segments, collectively held more than70% market share in terms of revenue in 2019.
Among all end users, hospitals is the leading segment, which is followed by cardiac catheterization laboratories. The hospitals segment is anticipated to expand at a CAGR of 14%over the forecast period.

North America and Europe, collectively held more than 70%revenue share in 2019, while South Asia is expected to show greater growth potential over the forecast period.

With the ongoing Covid-19pandemic wreaking havoc across the world, other non-emergency treatments have been deprioritized. As such in the near-term, the growth of the atrial fibrillation devices market will be slower than the average for the decade ahead.

“New product approvals and launches of ablation catheters along with increasing demand for minimally-invasive procedures offering increased longevity and safety profiles are driving the growth of the global atrial fibrillation devices market,” says a PMR analyst.

Planning To Introduce An Offbeat Product/Technology In The Atrial Fibrillation Devices Market? Go To “Purchase Now” To Have Our Atrial Fibrillation Devices Market Report! https://www.persistencemarketresearch.com/checkout/31531

New Product Launches – Key Strategic Focus of Market Players

Product approvals by the FDA for new AF devices are responsible for intense competition among market players. Numerous organizations are focusing on new product launches for electrophysiology, especially for atrial fibrillation.

For instance, in August 2016, Biosense Webster, Inc., a world leader in the treatment and diagnosis of heart arrhythmias, announced the launch of THERMOCOOL SMARTTOUCH SF catheters with contact force technology and a porous tip designed to optimize the treatment of atrial fibrillation.

Also, in January 2019, Abbott announced FDA approval for the TactiCath Contact Force Ablation Catheter. These winning strategies by leading players in the atrial fibrillation devices market are also being followed by regional and local players.

Atrial Fibrillation Devices Market: Competition Landscape

The global market is set to broaden its scope during the forecast period, stimulated by the rising prevalence of AF, worldwide. In addition, a favorable reimbursement scenario and increasing demand for minimally-invasive procedures have augmented the sales of atrial fibrillation devices.

The market is dominated by 4 major manufacturers – Biosense Webster, Inc. (Johnson & Johnson), Abbott Laboratories, Medtronic Plc, and Boston Scientific Corporation, with a revenue share of over 70% in 2019. These major manufacturers are focusing on manufacturing electrophysiology devices used specifically for atrial fibrillation procedure, such as ablation devices, intracardiac echocardiography catheters, and left atrial appendage (LAA) management devices.

Key market players covered by PMR include Biosense Webster, Inc. (Johnson & Johnson), Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, ArtiCure, Inc., Japan Lifeline Co., Biomerics, MicroPort Corporation, and CathRx, who are consolidating their position through mergers, acquisitions, and new product launches.

Want more insights?

PMR brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels, and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global atrial fibrillation devices market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The study provides compelling insights on the atrial fibrillation devices market on basis of product (diagnostics – conventional EP catheters, mapping catheters, CS catheters, and ICE catheters) and therapeutics – EP ablation, maze surgery, and LAA management devices), technology (radiofrequency, crythotherapy, ultrasound, and others), and end user (hospitals, ambulatory surgical centers, and cardiac catheterization laboratories), across seven major regions.

Access Related Reports-

Pressure Relief Devices Market @ https://www.prnewswire.com/news-releases/pressure-relief-devices-market-will-reach-at-a-cagr-of-5-5-from-2018-to-2026—persistence-market-research-300851493.html

'PMR' Related Reports-

Electrophysiology Ablation Market: https://www.persistencemarketresearch.com/market-research/electrophysiology-ablation-market.asp

Interventional Pulmonology Market: https://www.persistencemarketresearch.com/market-research/interventional-pulmonology-market.asp

Heart Valve Repair Replacement Market: https://www.persistencemarketresearch.com/market-research/heart-valve-repair-replacement-market.asp

Angiography Catheters Market: https://www.persistencemarketresearch.com/market-research/angiography-catheters-market.asp

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release A Stupendous CAGR Of 13% Between 2020 to 2030 To Be Clocked By The Atrial Fibrillation Devices Market here

News-ID: 2429902 • Views: 251

More Releases from Persistence Market Research

Connected Homes Market to Reach a Valuation Higher than US$ 138 Bn by 2026
Connected Homes Market 2021-2026 New Study Reports " Connected Homes Market 2021 Global Opportunities, Challenges, Strategies and Forecasts 2026" has been Added on PersistenceMarketResearch. Report Details: This report provides in depth study of “Connected Homes Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Connected Homes Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling,
Iot Market 2021: Global Projection by Key Players – IBM Corporation, Microsoft …
Iot Market 2021-2026 New Study Reports " Iot Market 2021 Global Opportunities, Challenges, Strategies and Forecasts 2026" has been Added on PersistenceMarketResearch. Report Details: This report provides in depth study of “Iot Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Iot Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the
Mobile Advertising Market 2021 Expected to reach US$ 120 Billion with 18.8% CAGR …
Mobile Advertising Market 2021-2025 New Study Reports " Mobile Advertising Market 2021 Global Opportunities, Challenges, Strategies and Forecasts 2025" has been Added on PersistenceMarketResearch. Report Details: This report provides in depth study of “Mobile Advertising Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Mobile Advertising Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling,
Building Automation Systems Market 2021 Expected to reach 248 Bn US$ with 11.3% …
Building Automation Systems Market 2021-2031 New Study Reports " Building Automation Systems Market 2021 Global Opportunities, Challenges, Strategies and Forecasts 2031" has been Added on PersistenceMarketResearch. Report Details: This report provides in depth study of “Building Automation Systems Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Building Automation Systems Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an

All 5 Releases


More Releases for Devices

Anesthesia Monitoring Devices Market
Anesthesia Monitoring Devices Market was valued at USD 1035 Million in 2016 and is expected to reach USD 3272 Million by 2026, at a CAGR of 12.2%.(Detailed analysis of the market CAGR is provided in the report)Anesthesia Monitoring Devices MarketThe use of anesthesia monitoring device is to monitor a patient’s response towards anesthetic drugs during a surgery procedure. The Market for anesthesia monitoring devices primarily depends on increasing life expectancy
Digital Microfluidic Devices Market
This report studies the Digital Microfluidic Devices Market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions. This report presents the worldwide Digital Microfluidic Devices market size (value, production and consumption), splits the breakdown (data status 2013-2018 and forecast to 2025), by manufacturers, region, type and application. This study also analyzes the market
Autotransfusion Devices Market
https://www.qandqmarketresearch.com/reports/autotransfusion-devices-market-20 This report studies Autotransfusion Devices in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Advancis Surgical Fresenius Kabi Haemonetics LivaNova Medtronic Terumo Corporation Atrium Medical Stryker ... On the basis of product, this report displays the production, revenue,
Mexico Cardiac Assist Devices
Mexico Cardiac Assist Devices Overview "Mexico Cardiac Assist Devices Market Outlook to 2025", provides key market data on the Mexico Cardiac Assist Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Intra-Aortic Balloon Pumps, Total Artificial Heart and Ventricular Assist Devices. Click here for sample report @ https://www.wiseguyreports.com/sample-request/3107735-mexico-cardiac-assist-devices-market-outlook-to-2025   Major Key Players: Abbott Laboratories Medtronic plc Getinge AB. Major Highlight of the report: The report also provides
4G (LTE) Devices Market
Persistence Market Research delivers key insights on the global 4G (LTE) devices market in a new publication titled “Global Market Study on 4G (LTE) Devices: Single Brand Store Distribution Channel Segment Expected to Witness Significant Growth Between 2016 and 2024” In terms of value, the global 4G (LTE) devices market is projected to register a healthy CAGR of 13.1% during the forecast period owing to various factors, regarding which Persistence
Aesthetic Devices-Medical Devices Pipeline Assessment 2017
ReportsWeb.com published “Aesthetic Devices-Medical Devices Pipeline Assessment 2017” from its database. The report reviews top companies involved and enlists all trials pertaining to the company. Report provides latest news for the past three months. Original Content: Publisher's Medical Devices sector report, "Aesthetic Devices-Medical Devices Pipeline Assessment, 2017" provides an overview of Aesthetic Devices currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at